Figure 2.
Impact of LSC17 status on prognosis. (A) DFS and (B) CIR and NRM (as competing risks) in 431 patients achieving CR or CRp after 1 or 2 induction courses per the dichotomic LSC17 status. (C) OS from diagnosis per LSC17 status in the total study population (N = 504).